featured
Impact of MS Disease-Modifying Treatments on Anti–SARS-CoV-2 Antibodies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti-SARS-CoV-2 Antibodies: An Observational Study
Neurol Neuroimmunol Neuroinflamm 2021 Sep 01;[EPub Ahead of Print], K Bigaut, L Kremer, T Fabacher, L Lanotte, MC Fleury, N Collongues, J de SezeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.